Stephen I Pelton MD is Professor of Pediatrics and Epidemiology at Boston University School of Medicine and Public Health and Director of Pediatrics Infectious Diseases at Boston Medical Center. Dr Pelton’s interests focus on the effects of recurrent disease and the long term effects of HIV, Hepatitis C and B, and Herpes among other things. Additionally, he organizes numerous clinical trials to discover new approaches to HIV prevention and treatment.
- Director (Section) of Pediatrics>Infectious Disease, Infectious Diseases, Pediatrics, Boston University School of Medicine
- Member, Pulmonary Center, Boston University
- Professor, Epidemiology, Boston University School of Public Health
- State University of New York at Buffalo, MD
- Queens College, City University of New York, BA
- Published on 4/26/2021
Weinberg A, Muresan P, Laimon L, Pelton SI, Goldblatt D, Canniff J, Zimmer B, Bone F, Newton L, Fenton T, Kiely J, Johnson MJ, Joao EC, Santos BR, Machado ES, Pinto JA, Chakhtoura N, Duarte G, Mussi-Pinhata MM. Safety, immunogenicity, and transplacental antibody transport of conjugated and polysaccharide pneumococcal vaccines administered to pregnant women with HIV: a multicentre randomised controlled trial. Lancet HIV. 2021 Apr 26. PMID: 33915104.
- Published on 3/30/2021
Pelton SI, Divino V, Postma MJ, Shah D, Mould-Quevedo J, DeKoven M, Krishnarajah G. A retrospective cohort study assessing relative effectiveness of adjuvanted versus high-dose trivalent influenza vaccines among older adults in the United States during the 2018-19 influenza season. Vaccine. 2021 04 22; 39(17):2396-2407. PMID: 33810903.
- Published on 3/26/2021
Baxter R, Aukes L, Pelton SI, Yee A, Klein NP, Gruber WC, Scott DA, Center KJ. Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease After Introduction Into Routine Pediatric Use. J Pediatric Infect Dis Soc. 2021 Mar 26; 10(2):141-150. PMID: 32415771.
- Published on 1/23/2021
Krishnarajah G, Divino V, Postma MJ, Pelton SI, Anupindi VR, DeKoven M, Mould-Quevedo J. Clinical and Economic Outcomes Associated with Cell-Based Quadrivalent Influenza Vaccine vs. Standard-Dose Egg-Based Quadrivalent Influenza Vaccines during the 2018-19 Influenza Season in the United States. Vaccines (Basel). 2021 Jan 23; 9(2). PMID: 33498724.
- Published on 1/1/2021
Wasserman M, Chapman R, Lapidot R, Sutton K, Dillon-Murphy D, Patel S, Chilson E, Snow V, Farkouh R, Pelton S. Twenty-Year Public Health Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines in US Children. Emerg Infect Dis. 2021; 27(6):1627-1636. PMID: 34013855.
- Published on 11/5/2020
Pelton SI, Lapidot R. Inferring public health and vaccine policies from epidemiology and whole genome sequencing of invasive pneumococcal isolates from a surveillance network. Clin Infect Dis. 2020 Nov 05. PMID: 33151276.
- Published on 8/7/2020
Pelton SI, Divino V, Shah D, Mould-Quevedo J, DeKoven M, Krishnarajah G, Postma MJ. Evaluating the Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to High-Dose Trivalent and Other Egg-Based Influenza Vaccines among Older Adults in the US during the 2017-2018 Influenza Season. Vaccines (Basel). 2020 Aug 07; 8(3). PMID: 32784684.
- Published on 7/30/2020
Divino V, Krishnarajah G, Pelton SI, Mould-Quevedo J, Anupindi VR, DeKoven M, Postma MJ. A real-world study evaluating the relative vaccine effectiveness of a cell-based quadrivalent influenza vaccine compared to egg-based quadrivalent influenza vaccine in the US during the 2017-18 influenza season. Vaccine. 2020 09 11; 38(40):6334-6343. PMID: 32739119.
- Published on 7/9/2020
Grammatico-Guillon L, Jafarzadeh SR, Laurent E, Shea K, Pasco J, Astagneau P, Adams W, Pelton S. Gradual decline in outpatient antibiotic prescriptions in paediatrics: A data warehouse-based 11-year cohort study. Acta Paediatr. 2021 02; 110(2):611-617. PMID: 32573837.
- Published on 6/10/2020
Thanawastien A, Joyce KE, Cartee RT, Haines LA, Pelton SI, Tweten RK, Killeen KP. Preclinical in vitro and in vivo profile of a highly-attenuated, broadly efficacious pneumolysin genetic toxoid. Vaccine. 2021 03 12; 39(11):1652-1660. PMID: 32532546.
View 280 more publications: View full profile at BUMC